Table 2 Index lesions and significant prostate cancers in MRI-visible and MRI-invisible lesions.

From: Concordance between biparametric MRI, transperineal targeted plus systematic MRI-ultrasound fusion prostate biopsy, and radical prostatectomy pathology

 

N

MRI-visible lesions

MRI-invisible lesions

Significant cancers

Index lesion

Significant cancers

Index lesion

Total

80

43 (53.7%)

75 (93.7%)

26 (32.5%)

5 (6.3%)

PI-RADS 3

20 (25.0%)

7 (35.0%)

18 (90.0%)

6 (30.0%)

2 (10.0%)

PI-RADS 4

33 (41.3%)

16 (48.5%)

31 (93.9%)

7 (21.2%)

2 (6.1%)

PI-RADS 5

27 (33.7%)

20 (74.1%)

26 (96.3%)

13 (48.1%)

1 (3.7%)

  1. MRI magnetic resonance imaging; PI-RADS Prostate Imaging–Reporting and Data System.
Back to article page